EKF Diagnostics Holdings plc (AIM: EKF), a worldwide manufacturer of in-vitro diagnostic devices, announces that subsidiaries of EKF have entered into a Settlement Agreement with HemoCue AB and HemoCue Inc (“HemoCue”) in relation to patent-related litigation in Germany and the US.
As a result of the Settlement Agreement all claims are mutually settled and finally resolved. Background information on the patent dispute is contained in the Company’s Admission Document dated 15 June 2010.
The effect of this is that EKF´s original design cuvette will continue to be sold in all countries other than China, Switzerland, Germany, Denmark, Spain, Finland, Great Britain, Italy, Japan, The Netherlands, Sweden, the United States and South Africa.
EKF´s new (symmetrical) design cuvette (U.S. Patent No. 8,110,160; EU Patent No. 2 024 089; German Patent No. 10 2006 025 477; Chinese Patent No. ZL 200780013023.4), whose new design ensures that blood can be collected at any angle without air bubbles collecting in the optical window thus reducing waste, will continue to be sold in all countries world-wide.